A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer.
about
Molecular imaging of integrin αvβ6 expression in living subjects.The role of integrins in TGFβ activation in the tumour stromaHigh-Throughput Approaches to the Development of Molecular Imaging Agents.The use of therapeutic peptides to target and to kill cancer cells.A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects.Combinatorial peptide libraries: mining for cell-binding peptides.Synthesis and characterization of a high-affinity {alpha}v{beta}6-specific ligand for in vitro and in vivo applications.MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells.High-throughput in vivo screening of targeted molecular imaging agents.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect.A Novel Strategy for Surface Modification of Superparamagnetic Iron Oxide Nanoparticles for Lung Cancer ImagingIntegrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer.18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.Therapeutic targeting of integrin αvβ6 in breast cancer.From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarkerCharacterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptideStructural guided scaffold phage display libraries as a source of bio-therapeutics.Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancerUnbiased Selection of Peptide-Peptoid Hybrids Specific for Lung Cancer Compared to Normal Lung Epithelial Cells.The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.Tumor-targeting peptides from combinatorial libraries.Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancerEpithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.Integrin signaling and lung cancer.99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.Mammalian plasma membrane proteins as potential biomarkers and drug targets.Tumor endothelial markers as a target in cancer.Tumor Targeting via Integrin Ligands.Novel oncoprotein EPS8: a new target for anticancer therapy.Identifying plant cell-surface receptors: combining 'classical' techniques with novel methods.αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer.Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.ImmunoPET Imaging of αvβ6 Expression Using an Engineered Anti-αvβ6 Cys-diabody Site-Specifically Radiolabeled with Cu-64: Considerations for Optimal Imaging with Antibody Fragments.
P2860
Q27007536-30ADB0B4-EECE-4C30-A902-DC3678AF6242Q28068373-B6007FB0-30BA-49C9-97F8-82D8B56A6E8DQ30275493-83577A59-1338-48BC-AB7C-929422E1357AQ30418414-0F825BB8-B35C-438D-97F4-D14F915F7B50Q30842985-6DB8BB8F-6249-4332-A05B-273A7CD8FB3FQ31144876-5B944DC5-2F54-482A-A7C4-F62D4404226EQ33444443-54D11339-96CA-4B6A-AFD2-9010C1230893Q33496895-73714D62-9C50-4359-A15F-CBAEFBD10A93Q33509447-01180F20-AD7B-489A-9669-1C7DAC3DF7CEQ33520512-765FEED3-1EAB-4F36-9B46-C328172ED534Q33686825-FFD7BF0E-632A-48DF-B047-BD34933CBBA5Q33874281-EB60D56E-8F1F-42B0-9CFB-BDB7428D28ABQ33955214-D2C36163-59B5-45D1-A324-A12A2BBEDD63Q34034171-0EE57DA6-8739-4653-ACBA-6A3EF125B7F5Q34120685-B614CA9A-2A6A-4D93-8D67-5EF8D2C13740Q34491680-9D1B3680-D455-4313-A0EE-7BFD2B8A4F4DQ34778502-64F1A714-F1FC-4A95-B076-A26700C09F7CQ34870617-4A258267-2686-4C00-AEAF-6EABB08B4CD3Q34946977-F3021458-2CC8-466B-8221-C615C3A68814Q35131992-B45B0973-3C64-48F4-A9CC-049B3C50127AQ35368323-916F2F15-0C2D-4F81-97DD-ACB00A131CACQ35729996-F607DD12-6D06-4AFE-A423-84C6EC49E1F5Q35824207-1564ADD1-2B19-4449-B5D5-DFB209C8E456Q36025238-4B8BF59E-0575-4DBE-8D31-83C89209F572Q36025723-3E4A717C-F504-4F37-8F82-2A33967FF56AQ36838793-05799656-B8D6-4255-B781-13B81F571D18Q37175519-A314723C-46FA-4717-94E8-0F2EBDEC42C1Q37232834-494C66F8-B7F8-484A-9A91-3848F7FF1C83Q37603527-605CD8BF-E1DD-451A-A92C-DC2407E391FAQ37688804-FED0EDAB-6507-475B-9026-E1BDD3B5D022Q37714107-8697879D-23B8-4789-974E-9CBA42C4B3FDQ37894617-D8A7C1BB-1BB0-460E-B095-621091B6F1CDQ38043525-6B9EF9CC-F7D1-4246-9E03-A6C68730CDE5Q38134759-0CC04A3A-5049-4534-9CF2-6B082AC1B2ACQ38150879-EC4F74F4-7FCF-489A-A50E-C05D228A0AE7Q38197332-7FB65BF0-FFFD-487F-B1C1-E8CD2B429390Q38242534-93ABE437-477B-4B6F-BECD-EC7D805DECFBQ38354023-1E6E8B3E-C5AA-40A1-A84F-7226A5C833E0Q38614156-60792833-3022-47B6-8B42-971BF1EA7132Q38666311-08BD9EF7-F250-49CA-B506-5FADB7F94A6B
P2860
A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@ast
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@en
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@nl
type
label
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@ast
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@en
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@nl
prefLabel
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@ast
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@en
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@nl
P2093
P1433
P1476
A peptide selected by biopanni ...... for nonsmall cell lung cancer.
@en
P2093
Aihua Bian
Anissa N Elayadi
Jack A Roth
Kathlynn C Brown
Kausar N Samli
Ludmila Prudkin
Michael J McGuire
Xian-Jin Xie
Ying-Horng Liu
P304
P356
10.1158/0008-5472.CAN-07-0245
P407
P577
2007-06-01T00:00:00Z